Big Pharma’s Busiest Deal-Makers In 2021 Were Less Prolific Than In 2020

 
• By Joseph Haas

Totals for aggregate deals and in the M&A, alliance and divestment categories were similar among the 10 busiest deal makers from 2020 to 2021, but COVID-19 may have driven a more hectic deal-making pace overall in 2020.

Back view image of young businessman standing against business sketch
2021 was a busy deal-making year in big pharma, with M&A up slightly and alliances down a bit • Source: Shutterstock

More from Growth

More from In Vivo